Modeling binding equilibrium in a competitive estrogen receptor binding assay - PubMed (original) (raw)
Modeling binding equilibrium in a competitive estrogen receptor binding assay
Jung-Hwan Kwon et al. Chemosphere. 2007 Oct.
Abstract
Although the free concentration is more significant in the environmental chemistry and toxicology of receptor-mediated toxicants, few studies have been conducted to use it as a dose-metric. The relative binding affinity of three model endocrine disrupting compounds, diethylstilbestrol (DES), ethynylestradiol (EE2), and bisphenol A (BPA), were evaluated using a competitive ELISA with human estrogen receptor alpha. After measuring the available receptors and the dissociation constant for 17beta-estradiol, binding inhibition curves using the free concentration as the dose-metric were obtained by assuming species equilibrium in the ELISA system and compared with apparent inhibition curves generated using the nominal concentration as the dose-metric. Because ligand binding to estrogen receptors may reduce its free concentration in the assay system, the differences between the two curves for free and nominal concentrations are more significant for more strongly binding ligands. The ratio of a compound's nominal concentration causing 50% inhibition (IC50) to the IC50 of DES, the positive control, was strongly affected by specific assay conditions, while that estimated by modeling free concentration is independent of receptor concentration, indicating that the free concentration is a better dose-metric for a competitive binding assay.
Similar articles
- Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
van Lipzig MM, ter Laak AM, Jongejan A, Vermeulen NP, Wamelink M, Geerke D, Meerman JH. van Lipzig MM, et al. J Med Chem. 2004 Feb 12;47(4):1018-30. doi: 10.1021/jm0309607. J Med Chem. 2004. PMID: 14761204 - A yeast assay based on the gilthead sea bream (teleost fish) estrogen receptor beta for monitoring estrogen mimics.
Passos AL, Pinto PI, Power DM, Canario AV. Passos AL, et al. Ecotoxicol Environ Saf. 2009 Jul;72(5):1529-37. doi: 10.1016/j.ecoenv.2009.02.004. Epub 2009 Mar 19. Ecotoxicol Environ Saf. 2009. PMID: 19303142 - Rapid modulation of synaptic plasticity by estrogens as well as endocrine disrupters in hippocampal neurons.
Ogiue-Ikeda M, Tanabe N, Mukai H, Hojo Y, Murakami G, Tsurugizawa T, Takata N, Kimoto T, Kawato S. Ogiue-Ikeda M, et al. Brain Res Rev. 2008 Mar;57(2):363-75. doi: 10.1016/j.brainresrev.2007.06.010. Epub 2007 Jul 28. Brain Res Rev. 2008. PMID: 17822775 Review. - In vitro receptor binding assays: general methods and considerations.
Bigott-Hennkens HM, Dannoon S, Lewis MR, Jurisson SS. Bigott-Hennkens HM, et al. Q J Nucl Med Mol Imaging. 2008 Sep;52(3):245-53. Epub 2008 May 13. Q J Nucl Med Mol Imaging. 2008. PMID: 18475249 Review.
Cited by
- Arsenite and cadmium promote the development of mammary tumors.
Divekar SD, Li HH, Parodi DA, Ghafouri TB, Chen R, Cyrus K, Foxworth AE, Fornace AJ, Byrne C, Martin MB. Divekar SD, et al. Carcinogenesis. 2020 Jul 14;41(7):1005-1014. doi: 10.1093/carcin/bgz176. Carcinogenesis. 2020. PMID: 31646340 Free PMC article. - Differential regulation of dopamine transporter function and location by low concentrations of environmental estrogens and 17beta-estradiol.
Alyea RA, Watson CS. Alyea RA, et al. Environ Health Perspect. 2009 May;117(5):778-83. doi: 10.1289/ehp.0800026. Epub 2009 Jan 5. Environ Health Perspect. 2009. PMID: 19479021 Free PMC article. - Differential regulation of aortic growth in male and female rodents is associated with AAA development.
Cho BS, Woodrum DT, Roelofs KJ, Stanley JC, Henke PK, Upchurch GR Jr. Cho BS, et al. J Surg Res. 2009 Aug;155(2):330-8. doi: 10.1016/j.jss.2008.07.027. Epub 2008 Aug 27. J Surg Res. 2009. PMID: 19111327 Free PMC article.